Seminars in Oncology
Volume 36, Issue 6 , Pages 493-497 , December 2009

Squamous Cell Carcinoma of the Esophagus: Treat With How Many Modalities?

References 

  1. Holmes RS, Vaughan TL. Epidemiology and pathogenesis of esophageal cancer. Semin Radiat Oncol. 2007;17:2–9
  2. Gebski V, Burmeister B, Smithers BM, Foo K, Zalcberg J, Simes J. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol. 2007;8:226–234
  3. Urschel JD, Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg. 2003;185:538–543
  4. Fiorica F, Di Bona D, Schepis F, Licata A, Shahied L, Venturi A, et al. Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis. Gut. 2004;53:925–930
  5. Krasna MJ, Jiao X. Thoracoscopic and laparoscopic staging for esophageal cancer. Semin Thorac Cardiovasc Surg. 2000;12:186–194
  6. Herskovic A, Martz K, al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med. 1992;326:1593–1598
  7. Stahl M, Stuschke M, Lehmann N, et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol. 2005;23:2310–2317
  8. Bedenne L, Michel P, Bouche O, Milan C, Mariette C, Conroy T, et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol. 2007;25:1160–1168
  9. Monzajeb AM, Farmer MR, Mattern M, Mebea A, Levine EA, Geisinger KR, et al. Patterns of failure for esophageal cancer patients optimally staged with F-18-FDG-PET and observed after chemo-radiotherapy. Int J Radiat Oncol Biol Phys. 2007;69(Suppl):S274
  10. Kim MK, Cho KJ, Park SI, Kim YH, Kim JH, Song HY, et al. Initial stage affects survival even after complete pathologic remission is achieved in locally advanced esophageal cancer: analysis of 70 patients with pathologic major response after preoperative chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2009;75:115–121
  11. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TP. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 1996;335:462–467
  12. Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol. 2001;19:305–313
  13. Swisher S, Winter K, Komaki R, Ajani J, Wu T, Hofstetter W, et al. A phase II study of a paclitaxel based chemoradiation regimen with selective surgical salvage for resectable locoregionally advanced esophageal cancer: initial reporting of RTOG 0246. Int J Radiat Oncol Biol Phys. 2007;60(Suppl):S106

PII: S0093-7754(09)00164-X

doi: 10.1053/j.seminoncol.2009.09.002

Seminars in Oncology
Volume 36, Issue 6 , Pages 493-497 , December 2009

Article Tools

* Image Usage & Resolution